Lubris
2 known investors
Lübris BioPharma develops recombinant human lubricin for treating dry eye, osteoarthritis, and age/inflammation-related conditions. The company's therapeutic approach uses a naturally occurring protein that protects tissues from friction-related damage.
BiotechHealthtechMedical Devices
Investors · 2
Frequently asked questions
- What does Lubris do?
- Lübris BioPharma develops recombinant human lubricin for treating dry eye, osteoarthritis, and age/inflammation-related conditions. The company's therapeutic approach uses a naturally occurring protein that protects tissues from friction-related damage.
- Who are Lubris's investors?
- Lubris's investors include Tarnagulla Ventures, Thynk Capital.